CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 66 filers reported holding CHEMOCENTRYX INC in Q2 2014. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $437,000 | +246.8% | 59,051 | +183.1% | 0.01% | +266.7% |
| Q3 2016 | $126,000 | +48.2% | 20,857 | +100.9% | 0.00% | +50.0% |
| Q2 2015 | $85,000 | -54.5% | 10,381 | -62.1% | 0.00% | -33.3% |
| Q4 2014 | $187,000 | +183.3% | 27,387 | +142.1% | 0.00% | +200.0% |
| Q2 2014 | $66,000 | -42.6% | 11,312 | -35.1% | 0.00% | 0.0% |
| Q1 2014 | $115,000 | +57.5% | 17,424 | +38.2% | 0.00% | 0.0% |
| Q4 2013 | $73,000 | – | 12,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |